Triple
T686646
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | Food and Drug Administration |
E13297
|
entity |
| Predicate | hasDivision |
P35
|
FINISHED |
| Object |
Center for Devices and Radiological Health
The Center for Devices and Radiological Health is the U.S. FDA division responsible for regulating medical devices and radiation-emitting products to ensure their safety and effectiveness.
|
E88388
|
NE FINISHED |
How this triple was built (4 steps)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
NER
Named-entity recognition
gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: Center for Devices and Radiological Health | Statement: [Food and Drug Administration, hasDivision, Center for Devices and Radiological Health]
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: Center for Devices and Radiological Health Context triple: [Food and Drug Administration, hasDivision, Center for Devices and Radiological Health]
-
A.
Center for Biologics Evaluation and Research
The Center for Biologics Evaluation and Research is the U.S. regulatory body responsible for overseeing the safety, efficacy, and quality of biological products such as vaccines, blood products, and gene therapies.
-
B.
Center for Drug Evaluation and Research
The Center for Drug Evaluation and Research is the U.S. FDA division responsible for overseeing the safety, effectiveness, and quality of prescription and over-the-counter drugs.
-
C.
Food and Drug Administration
The Food and Drug Administration is a U.S. federal agency responsible for protecting public health by regulating food, drugs, medical devices, and other consumer products.
-
D.
National Center for Toxicological Research
The National Center for Toxicological Research is a U.S. federal research facility that conducts scientific studies to support the safety evaluation and regulatory decisions of the Food and Drug Administration.
-
E.
Bureau of Health Care Safety and Quality
The Bureau of Health Care Safety and Quality is a division of Massachusetts state government responsible for overseeing and improving the safety, quality, and regulatory compliance of health care facilities and services.
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
NEDg
Description generation
gpt-5.1
Instruction
Generate a one-sentence description of the target entity. You are given a context triple in the form (subject, predicate, object), where the object is the target entity. # Instructions Use the triple to infer relevant information about the entity. Describe the entity based on what is most defining, well-known. Avoid repeating the information from the triple, unless really essential. # Response Format Return only the sentence: "Description: [one-sentence description of the target entity]"
Input
Entity: Center for Devices and Radiological Health Triple: [Food and Drug Administration, hasDivision, Center for Devices and Radiological Health]
Generated description
The Center for Devices and Radiological Health is the U.S. FDA division responsible for regulating medical devices and radiation-emitting products to ensure their safety and effectiveness.
NED2
Entity disambiguation (via description)
gpt-5-mini-2025-08-07
Target entity: Center for Devices and Radiological Health Target entity description: The Center for Devices and Radiological Health is the U.S. FDA division responsible for regulating medical devices and radiation-emitting products to ensure their safety and effectiveness.
-
A.
Center for Biologics Evaluation and Research
The Center for Biologics Evaluation and Research is the U.S. regulatory body responsible for overseeing the safety, efficacy, and quality of biological products such as vaccines, blood products, and gene therapies.
-
B.
Center for Drug Evaluation and Research
The Center for Drug Evaluation and Research is the U.S. FDA division responsible for overseeing the safety, effectiveness, and quality of prescription and over-the-counter drugs.
-
C.
Food and Drug Administration
The Food and Drug Administration is a U.S. federal agency responsible for protecting public health by regulating food, drugs, medical devices, and other consumer products.
-
D.
National Center for Toxicological Research
The National Center for Toxicological Research is a U.S. federal research facility that conducts scientific studies to support the safety evaluation and regulatory decisions of the Food and Drug Administration.
-
E.
Bureau of Health Care Safety and Quality
The Bureau of Health Care Safety and Quality is a division of Massachusetts state government responsible for overseeing and improving the safety, quality, and regulatory compliance of health care facilities and services.
- F. None of above. chosen
Provenance (5 batches)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69a4933e0f98819097d22766c49b61b8 |
completed | March 1, 2026, 7:27 p.m. |
| NER | Named-entity recognition | batch_69a4a093ac988190bb339616a3ed5adb |
completed | March 1, 2026, 8:24 p.m. |
| NED1 | Entity disambiguation (via context triple) | batch_69a64a53c068819089e66347da55710b |
completed | March 3, 2026, 2:41 a.m. |
| NEDg | Description generation | batch_69a64fa842b481909a5e6ee1c9f398c0 |
completed | March 3, 2026, 3:04 a.m. |
| NED2 | Entity disambiguation (via description) | batch_69a650b66fcc8190bf0ad91ead93f253 |
completed | March 3, 2026, 3:08 a.m. |
Created at: March 1, 2026, 7:36 p.m.